Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Alberts

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Nuklearmedizin. Nuclear Medicine|May 15, 2019
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomographyViktor Fech, Ian Alberts, Axel Rominger, et al.
Bioorganic & Medicinal Chemistry|July 8, 2020
Structural manipulation of aporphines via C10 nitrogenation leads to the identification of new 5-HT<sub>7A</sub>R ligandsAnupam Karki, Hari K Namballa, Ian Alberts, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2022
Assessment of malignancy and PSMA expression of uncertain bone foci in [<sup>18</sup>F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsiesBernd Vollnberg, Ian Alberts, Vera Genitsch, et al.
Clinical Oral Investigations|April 8, 2010
Physical properties of self-, dual-, and light-cured direct core materialsStefan Rüttermann, Ian Alberts, Wolfgang H M Raab, et al.
Nuklearmedizin. Nuclear Medicine|November 26, 2019
PSMA-negative prostate cancer and the continued value of choline-PET/CTIan Alberts, Christos Sachpekidis, Viktor Fech, et al.
Nuklearmedizin. Nuclear Medicine|March 20, 2020
Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CTViktor Fech, Christos Sachpekidis, Ian Alberts, et al.
Nuklearmedizin. Nuclear Medicine|January 26, 2021
Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumoniaClemens Mingels, Bernd Vollnberg, Axel Rominger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2022
Diagnostic accuracy of [<sup>18</sup>F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancerClemens Mingels, Karl Peter Bohn, Axel Rominger, et al.
Clinical Nuclear Medicine|November 4, 2021
PSMA-Ligand Uptake in Disseminated Epidermoid Cysts in a PSMA PET/CT of a Patient With Recurrent Prostate CancerKarl Peter Bohn, Ian Alberts, Clemens Mingels, et al.
Bioorganic Chemistry|June 30, 2022
Further studies on C2'-substituted 1-phenylbenzazepines as dopamine D1 receptor ligandsRajan Giri, Hari K Namballa, Ananta Sarker, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Nuklearmedizin. Nuclear Medicine|May 15, 2019
PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomographyViktor Fech, Ian Alberts, Axel Rominger, et al.
Bioorganic & Medicinal Chemistry|July 8, 2020
Structural manipulation of aporphines via C10 nitrogenation leads to the identification of new 5-HT<sub>7A</sub>R ligandsAnupam Karki, Hari K Namballa, Ian Alberts, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2022
Assessment of malignancy and PSMA expression of uncertain bone foci in [<sup>18</sup>F]PSMA-1007 PET/CT for prostate cancer-a single-centre experience of PET-guided biopsiesBernd Vollnberg, Ian Alberts, Vera Genitsch, et al.
Clinical Oral Investigations|April 8, 2010
Physical properties of self-, dual-, and light-cured direct core materialsStefan Rüttermann, Ian Alberts, Wolfgang H M Raab, et al.
Nuklearmedizin. Nuclear Medicine|November 26, 2019
PSMA-negative prostate cancer and the continued value of choline-PET/CTIan Alberts, Christos Sachpekidis, Viktor Fech, et al.
Nuklearmedizin. Nuclear Medicine|March 20, 2020
Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CTViktor Fech, Christos Sachpekidis, Ian Alberts, et al.
Nuklearmedizin. Nuclear Medicine|January 26, 2021
Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumoniaClemens Mingels, Bernd Vollnberg, Axel Rominger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2022
Diagnostic accuracy of [<sup>18</sup>F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancerClemens Mingels, Karl Peter Bohn, Axel Rominger, et al.
Clinical Nuclear Medicine|November 4, 2021
PSMA-Ligand Uptake in Disseminated Epidermoid Cysts in a PSMA PET/CT of a Patient With Recurrent Prostate CancerKarl Peter Bohn, Ian Alberts, Clemens Mingels, et al.
Bioorganic Chemistry|June 30, 2022
Further studies on C2'-substituted 1-phenylbenzazepines as dopamine D1 receptor ligandsRajan Giri, Hari K Namballa, Ananta Sarker, et al.
Pageof 10